Acrobiosystems Co.,Ltd. (SHE:301080)
China flag China · Delayed Price · Currency is CNY
78.70
-2.90 (-3.55%)
At close: Sep 11, 2026

Acrobiosystems Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
180.12165.57123.83153.59203.73174.21
Depreciation & Amortization
66.5665.8553.2542.0234.513.94
Other Amortization
16.8122.2819.0217.459.63.99
Loss (Gain) From Sale of Assets
-0.07-0.070.35--0.21-0.28
Asset Writedown & Restructuring Costs
33.374.11037.7624.225.7
Loss (Gain) From Sale of Investments
-11.25-10.571.48-5.37-21.63-8.1
Provision & Write-off of Bad Debts
-1.24-0.030.031.711.03-
Other Operating Activities
61.1237.0336.09-9.34-4.430.4
Change in Accounts Receivable
59.5874.15-41.23-56.05-17.64-26.27
Change in Inventory
-117.66-131.03-83.21-81.32-52.91-34.44
Change in Accounts Payable
93.58135.69-6.1429.8137.2217.4
Change in Other Net Operating Assets
11.611.6-6.37-5.937.251.18
Operating Cash Flow
375.45355.7484.71111.2202.19138.01
Operating Cash Flow Growth
198.22%319.97%-23.82%-45.00%46.51%43.02%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-244.62-205.08-167.26-128.69-284.29-61.7
Sale of Property, Plant & Equipment
1.211.214.7100.35-
Cash Acquisitions
---1.731.92--
Investment in Securities
-285.02-220.98276.980.19-913.61-722.05
Other Investing Activities
113.46104.710.125.2621.118.05
Investing Cash Flow
-414.97-320.14112.85-91.32-1,176-775.7

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
---6--
Long-Term Debt Issued
-55.2897.46---
Total Debt Issued
45.4155.2897.466--
Long-Term Debt Repaid
--110.85-42.78-31.93-17.61-9.54
Lease Payments
-13.04-23.39-26.78-31.93-17.61-9.54
Net Debt Issued (Repaid)
12.78-55.5754.68-25.93-17.61-9.54
Issuance of Common Stock
--7.06-13.52,118
Repurchase of Common Stock
-23.85-23.85-12-10--
Common Dividends Paid
-148.6-85.55-108.21-120-120-
Other Financing Activities
-22.01-14.44----18.21
Financing Cash Flow
-181.68-179.42-58.48-155.93-124.112,090

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-21.8-7.767.6513.856.42-2.26
Net Cash Flow
-243-151.59146.73-122.2-1,0921,450

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
130.84150.66-82.56-17.49-82.176.31
Free Cash Flow Growth
------6.39%
Free Cash Flow Margin
13.77%17.98%-12.80%-3.22%-17.30%19.82%
Free Cash Flow Per Share
0.790.90-0.49-0.10-0.490.57
Levered Free Cash Flow
-155.11-118.22-156.74-25.36-173.0141.41
Unlevered Free Cash Flow
-155.11-116.54-154.52-23.67-171.1742.13
Free Cash Flow After Leases
117.79127.26-109.34-49.42-99.766.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
112.9653.9760.5548.6736.4341.4
Change in Working Capital
30.0471.55-149.35-126.63-44.62-51.85